Variant report
Variant | esv17165 |
---|---|
Chromosome Location | chr3:163737909-163740820 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:163738641..163741233-chr3:163742705..163744722,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149730319 | chr3:163738635-163738636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571324594 | chr3:163738636-163738637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12629562 | chr3:163738741-163738742 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs553568620 | chr3:163738749-163738750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573916959 | chr3:163738764-163738765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35513417 | chr3:163738770-163738771 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs530535734 | chr3:163738853-163738854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192904843 | chr3:163738929-163738930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575541114 | chr3:163738930-163738931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555809734 | chr3:163738946-163738947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548972459 | chr3:163738953-163738954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559675075 | chr3:163738971-163738972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533486856 | chr3:163738975-163738976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34348114 | chr3:163738977-163738978 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs144554016 | chr3:163739009-163739010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529537543 | chr3:163739042-163739043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549406637 | chr3:163739076-163739077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34355574 | chr3:163739095-163739096 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs531164987 | chr3:163739100-163739101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551380773 | chr3:163739101-163739102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34114597 | chr3:163739107-163739108 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs533629090 | chr3:163739134-163739135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547120351 | chr3:163739178-163739179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577016627 | chr3:163739211-163739212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34301772 | chr3:163739218-163739219 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs536083275 | chr3:163739266-163739267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139379797 | chr3:163739268-163739269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576288047 | chr3:163739304-163739305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185173409 | chr3:163739334-163739335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188493172 | chr3:163739341-163739342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144156766 | chr3:163739377-163739378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs75397168 | chr3:163739378-163739379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs76495211 | chr3:163739399-163739400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115239445 | chr3:163739412-163739413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146781501 | chr3:163739422-163739423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs193111715 | chr3:163739423-163739424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs369691728 | chr3:163739439-163739440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529160927 | chr3:163739479-163739480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140539170 | chr3:163739507-163739508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs532049553 | chr3:163739521-163739522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551824042 | chr3:163739565-163739566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564518486 | chr3:163739566-163739567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184590211 | chr3:163739575-163739576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547081490 | chr3:163739577-163739578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs115786707 | chr3:163739580-163739581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs536013190 | chr3:163739589-163739590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142869201 | chr3:163739615-163739616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569815383 | chr3:163739625-163739626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538908240 | chr3:163739662-163739663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs539249770 | chr3:163739718-163739719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163738600-163739200 | Enhancers | Dnd41 | blood |
2 | chr3:163739000-163739400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr3:163739400-163740400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr3:163740400-163740600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |